HALOZYME THERAPEUTICS, INC. Quarterly Current Ratio in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Halozyme Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q2 2024.
  • Halozyme Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 708 %, a 14.5% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 708 +89.4 +14.5% Jun 30, 2024
Q1 2024 686 +207 +43.1% Mar 31, 2024
Q4 2023 690 +159 +30.1% Dec 31, 2023
Q3 2023 660 +81.7 +14.1% Sep 30, 2023
Q2 2023 618 -23.3 -3.63% Jun 30, 2023
Q1 2023 480 -382 -44.4% Mar 31, 2023
Q4 2022 530 -329 -38.3% Dec 31, 2022
Q3 2022 578 +114 +24.5% Sep 30, 2022
Q2 2022 642 +195 +43.5% Jun 30, 2022
Q1 2022 862 +433 +101% Mar 31, 2022
Q4 2021 860 +468 +120% Dec 31, 2021
Q3 2021 465 -648 -58.2% Sep 30, 2021
Q2 2021 447 -261 -36.9% Jun 30, 2021
Q1 2021 429 -41.3 -8.79% Mar 31, 2021
Q4 2020 392 +31 +8.61% Dec 31, 2020
Q3 2020 1.11K +817 +277% Sep 30, 2020
Q2 2020 708 +413 +140% Jun 30, 2020
Q1 2020 470 +161 +52.2% Mar 31, 2020
Q4 2019 360 +26.5 +7.92% Dec 31, 2019
Q3 2019 296 -65.9 -18.2% Sep 30, 2019
Q2 2019 295 -78.4 -21% Jun 30, 2019
Q1 2019 309 -79.1 -20.4% Mar 31, 2019
Q4 2018 334 -43.8 -11.6% Dec 31, 2018
Q3 2018 361 -28.4 -7.28% Sep 30, 2018
Q2 2018 373 -61 -14% Jun 30, 2018
Q1 2018 388 -110 -22.1% Mar 31, 2018
Q4 2017 378 -150 -28.4% Dec 31, 2017
Q3 2017 390 -80.3 -17.1% Sep 30, 2017
Q2 2017 434 +3.52 +0.82% Jun 30, 2017
Q1 2017 498 +116 +30.3% Mar 31, 2017
Q4 2016 528 +144 +37.6% Dec 31, 2016
Q3 2016 470 -17.7 -3.63% Sep 30, 2016
Q2 2016 431 -103 -19.3% Jun 30, 2016
Q1 2016 383 -173 -31.1% Mar 31, 2016
Q4 2015 384 -157 -29% Dec 31, 2015
Q3 2015 488 +1.51 +0.31% Sep 30, 2015
Q2 2015 534 +108 +25.4% Jun 30, 2015
Q1 2015 555 +189 +51.7% Mar 31, 2015
Q4 2014 541 +191 +54.6% Dec 31, 2014
Q3 2014 486 +85.9 +21.5% Sep 30, 2014
Q2 2014 426 -58 -12% Jun 30, 2014
Q1 2014 366 -250 -40.5% Mar 31, 2014
Q4 2013 350 -321 -47.9% Dec 31, 2013
Q3 2013 400 -192 -32.5% Sep 30, 2013
Q2 2013 484 -131 -21.4% Jun 30, 2013
Q1 2013 616 +160 +35% Mar 31, 2013
Q4 2012 671 Dec 31, 2012
Q3 2012 593 Sep 30, 2012
Q2 2012 615 Jun 30, 2012
Q1 2012 456 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.